EUVIMEDOpdag EUVIMED
Open access

EphA2-targeted alpha-particle theranostics for enhancing PDAC treatment

Ajay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, Gabriela Lofland, Sophia Y Chen, Ian Marsh, Peyton T Fair, Robert F Hobbs, Todd M Armstrong, Elizabeth M Jaffee, Edward W Gabrielson, Lei Zheng and 1 more

Theranostics · 2025-03-18 · 15 (10) · 4229-4246

DOI: 10.7150/thno.106948 ↗

At a glance

Journal article in Theranostics, published on 2025-03-18. Written by Ajay Kumar Sharma and 12 co-authors. Institution: The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA. Major MEDLINE topics: Receptor, EphA2, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Theranostic Nanomedicine. Cited 20 times so far (Crossref). The full text is freely available in PubMed Central. Funded by: NCI NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Subjects

MeSH terms (MEDLINE)

Receptor, EphA2Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalTheranostic NanomedicineAlpha ParticlesHumansAnimalsCell Line, TumorMicePositron-Emission TomographyXenograft Model Antitumor AssaysGallium RadioisotopesRadiopharmaceuticalsMice, NudePrecision Medicine

Author keywords

Alpha-particle therapyGallium-68ImagingPETPancreatic cancerPeptide radiopharmaceuticalsRadiotherapy

Substances

Receptor, EphA2EPHA2 protein, humanGallium RadioisotopesRadiopharmaceuticalsGallium-68

Authors and institutions

  • The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center and the Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Department of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.

Funding

  • NCI NIH HHS

Cite

APA

Sharma, A. K., Gupta, K., Mishra, A., Lofland, G., Chen, S. Y., Marsh, I., Fair, P. T., Hobbs, R. F., Armstrong, T. M., Jaffee, E. M., Gabrielson, E. W., Zheng, L., & Nimmagadda, S. (2025). EphA2-targeted alpha-particle theranostics for enhancing PDAC treatment. Theranostics, 15(10), 4229-4246. https://doi.org/10.7150/thno.106948

Vancouver

Sharma AK, Gupta K, Mishra A, Lofland G, Chen SY, Marsh I, et al. EphA2-targeted alpha-particle theranostics for enhancing PDAC treatment. Theranostics. 2025;15(10):4229-4246. doi:10.7150/thno.106948

BibTeX
@article{Sharma2025,
  author = {Sharma, Ajay Kumar and Gupta, Kuldeep and Mishra, Akhilesh and Lofland, Gabriela and Chen, Sophia Y and Marsh, Ian and Fair, Peyton T and Hobbs, Robert F and Armstrong, Todd M and Jaffee, Elizabeth M and Gabrielson, Edward W and Zheng, Lei and Nimmagadda, Sridhar},
  title = {EphA2-targeted alpha-particle theranostics for enhancing PDAC treatment},
  journal = {Theranostics},
  year = {2025},
  volume = {15},
  number = {10},
  pages = {4229--4246},
  doi = {10.7150/thno.106948}
}
Start for free →